22nd Century Group, Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Consensus

—

Average target

$82.50

Implied upside

—

Analysts

—

Why Is XXII Down 17.92% Today?

22nd Century Group shares are experiencing a significant selloff today despite announcing what could be considered positive business developments, including a partnership with Gopuff and expansion into 13 new states. The sharp decline suggests the market may be pricing in concerns about execution, valuation, or broader industry headwinds that outweigh the near-term distribution gains.

Bottom line: 22nd Century Group announced strategically important business developments today, but the market's sharp 17.92% decline suggests investors are concerned about execution risk, profitability timelines, or valuation relative to these initiatives. While the Gopuff partnership and retail expansion provide legitimate growth catalysts, the bearish price action indicates skepticism about near-term financial returns and highlights the importance of monitoring upcoming earnings reports and early performance metrics from these channels.